Neurogene Inc. (NASDAQ:NGNE) Receives $59.80 Consensus PT from Brokerages
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are presently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among […]
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are presently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among […]
